Meeting
2017 ASCO-SITC Clinical Immuno-Oncology Symposium
Correlation of T-cell infiltration and clonality with PD-L1 expression in soft tissue sarcomas.
Authors
Seth Pollack
Fred Hutchinson Cancer Research Center, Seattle, WA
Seth Pollack, Qianchuan He, Jennifer Yearley, Ryan O Emerson, Marissa Vignali, Yuzheng Zhang, Mary Redman, Elizabeth Trice Loggers, Lee D. Cranmer, Venu Gopal Pillarisetty, Robert Ricciotti, Benjamin L Hoch, Erin Murphy, Terrill K McClanahan, Wendy Blumenschein, Steven Matthew Townson, Sharon Benzeno, Stanley R. Riddell, Robin Lewis Jones
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Poster Session B
Track
Biomarkers and Inflammatory Signatures,Humoral Immunity for Diagnosis and Therapy,Immune Checkpoints and Stimulatory Receptors,Modulating Innate Immunity,Therapies Targeting T cells
Sub Track
Novel Biomarker Approaches
Citation
J Clin Oncol 35, 2017 (suppl 7S; abstract 23)
DOI
10.1200/JCO.2017.35.7_suppl.23
Abstract #
23
Poster Bd #
C6
Abstract Disclosures
Similar Posters
Poster
2018 ASCO Annual Meeting
Distinct immune signatures in chronic lymphocytic leukemia (CLL) and Richter’s syndrome (RS).
First Author: Yucai Wang
Poster
2015 ASCO Annual Meeting
Anti-tumor efficacy and PD-L1 expression in the tumor microenvironment after poxvirus-based active immunotherapy and PD-1 blockade.
First Author: Stefanie J Mandl
Poster
2015 Genitourinary Cancers Symposium
Frequent expression of PD-L1 in testicular germ cell tumors.
First Author: Christian Daniel Fankhauser
Poster
2022 ASCO Annual Meeting
Phase 1 study of SGN-PDL1V, a novel, investigational vedotin antibody–drug conjugate directed to PD-L1, in patients with advanced solid tumors (SGNPDL1V-001, trial in progress).
First Author: Amita Patnaik